Clinical trial
Valproic Acid and Its Effects on HIV Latent Reservoirs
NCT00289952 · Jean-Pierre Routy, Other · Completed
Key facts
| NCT number | NCT00289952 |
|---|---|
| Title | Valproic Acid and Its Effects on HIV Latent Reservoirs |
| Official title | Use of Valproic Acid to Purge HIV From Resting CD4+ Memory Cells/ A Proof-of-concept Study |
| Lead sponsor | Jean-Pierre Routy, Other |
| Collaborators | Canadian Foundation for AIDS Research (CANFAR) CIHR Canadian HIV Trials Network |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Valproic Acid, HAART |
| Enrollment | 50 |
| Start date | Jun 1, 2006 |
| Primary completion | Dec 1, 2012 |
| Completion | Dec 1, 2012 |
| First posted | Feb 10, 2006 |
| Last update posted | Mar 15, 2023 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: